How much does a box of Panitumumab cost?

Panitumumab (Panitumumab) is the first and only fully human monoclonal anti-epidermal growth factor receptor (EGFR) antibody approved by the FDA for this patient population. It is used for the treatment of patients with KRAS mutation-negative metastatic colorectal cancer. It is understood that the original version of panitumumab has not yet been launched in China, and therefore it has not been covered by medical insurance. The price of the Hong Kong original version of panitumumab 100mg/5mL sold in Hong Kong, China, may be around 9,000 RMB (the price may fluctuate due to exchange rates). There are currently no generic drugs of Panitumumab on the market. If a patient has a need to purchase Panitumumab, please consult a medical consultant for specific prices and more drug information.